Lifecycle Leader - Ophtalmology

Roche•South San Francisco, CA

About The Position

Roche’s Global Pharma Strategy (GPS) team shapes the strategic direction of its innovative product portfolio, transforming scientific discoveries into accessible healthcare solutions. The Lifecycle Leader leads one or more asset strategies and portfolios from research through to patients and is accountable to the Late Stage Portfolio Committee (LSPC) for maximizing product value for patients, society, and the company. The role provides integrated, global, cross-functional leadership and works across early and late development, medical affairs, technical, commercial, and external partner teams. The Lifecycle Leader develops long-term asset strategy, supports earlier lifecycle involvement and transitions from early to late-stage development, and contributes to licensing and other business development activities. The role aligns teams around strategy and decisions, builds a culture of accountability, collaboration, inclusion, and trust, and serves as a thought partner to internal and external stakeholders. It also owns resource requests and appropriate utilization, delivery of adjusted net present value (aNPV) commitments, and ongoing assessment of asset strategy and value opportunities. This includes proposing and delivering indications, formulations, devices, diagnostics, digital tools, and evidence-generation strategies to address appropriate treatable populations. Success is measured by maximizing lifecycle value, delivering product strategy on time, on target, and within budget, meeting milestones and financial targets, and developing and leading a high-performing team in a changing internal and external context. The primary posting location is Basel; compensation details are provided where pay transparency applies, and information about other locations may be provided later in the hiring process.

Requirements

Bachelor’s degree; a marketing, business management, or life sciences discipline is preferred.
Demonstrable accomplishments developing and overseeing execution of breakthrough development and/or commercial strategies that produced considerable financial results.
Product management and launch experience.
Ability to quickly understand and navigate technical, supply, development, and regulatory challenges.
Deep understanding of global health systems and access and reimbursement challenges.
Outstanding leadership skills and a proven record of building teams and influencing in a cross-functional environment.
Exceptional strategic orientation and agility, including the ability to develop a long-term vision and a deep understanding of the global pharmaceutical or biotechnology industry.
Exceptional ability to synthesize and summarize strategic concepts amid ambiguity and deliver key milestones, product targets, and maximum lifecycle value.
Ability to collaborate end-to-end across early- to late-stage development and cross-functionally within the Ophthalmology portfolio and broader enterprise.

Nice To Haves

MD, PhD, another relevant graduate or postgraduate degree, or MBA, depending on the product lifecycle.
Therapeutic-area experience.

Responsibilities

Shape the long-term vision and strategy for one or more asset programs in partnership with early development, Pharma Development, Global Pharma Strategy, Pharma Development Medical Affairs leads, and external partners.
Contribute earlier in the lifecycle to support a seamless transition from early to late-stage development, including providing input to asset teams at critical points such as a pivotal enabling Clinical Development Plan.
Support relevant early development asset teams, licensing, and other business development activities.
Drive alignment and integrated decision-making with Global Development, Global Technical, and Commercial Leadership teams to realize asset potential within asset, disease-area, and therapeutic-area strategies.
Promote asset, disease-area, and enterprise mindsets and develop team capability in line with OnePharmaStrategy.
Lead and inspire teams around a shared vision and foster accountability, collaboration, inclusion, and trust.
Serve as a thought partner and sounding board for GPS and cross-organization teams and internal and external stakeholders.
Be accountable for resource requests, appropriate resource utilization, and delivery of adjusted net present value (aNPV) commitments to the Late Stage Portfolio Committee.
Continuously assess and evolve asset strategy in response to external dynamics, opportunities, and disease-area strategy, using value levers to maximize asset potential.
Provide integrated leadership to propose and deliver indications, formulations, devices, diagnostics, digital tools, and evidence-generation strategies to address the appropriate treatable population.
Deliver product strategy on time, on target, and within budget, including achievement of key milestones and financial targets.
Develop and lead a high-performing team to create and deliver asset strategy in a dynamic context.